Lin Liu, Jian Gao, Ruwen Wang, Jinghua Yan, Jingtian Zhang, Huandong Lin, Shengxiang Rao, Xiuzhong Yao, Weiyun Wu, Bian Hua, Zhitian Zhang, Jiaojiao Liu, Shanshan Guo, Xin Gao, Hongmei Yan
AIM: The aim of this study was to investigate the effects of Insulin Glargine and Exenatide on the muscle mass of patients with newly diagnosed type 2 diabetes (T2DM) and nonalcoholic fatty liver disease (NAFLD). METHODS: We performed a post-hoc analysis of our previously study, a 24-week randomized controlled multicenter clinical trial (ClinicalTrials.gov, NCT02303730). Seventy-six patients were randomly assigned 1:1 to receive Insulin Glargine or Exenatide treatment...
July 31, 2023: Experimental and Clinical Endocrinology & Diabetes